Evoco Labs Co., Ltd. – Trademark Portfolio

Entity Type: 99

Evoco Labs Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ORKA and AI DENOISE. The owner is based in Shanghai.

315, 2nd Floor, Building 1, No. 58

Shanghai 200120 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ORKA
ORKA
Registered 2020

Trademark Classifications

Evoco Labs Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Evoco Labs Co., Ltd. have?

Evoco Labs Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Evoco Labs Co., Ltd. file in?

Evoco Labs Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Evoco Labs Co., Ltd.'s most well-known trademarks?

Evoco Labs Co., Ltd.'s registered trademark portfolio includes well-known marks such as ORKA and AI DENOISE. These are among 2 currently registered trademarks in the portfolio.

What is Evoco Labs Co., Ltd.'s trademark registration success rate?

Evoco Labs Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.